The Effectiveness of 4D Image Acquisition and Post-processing With Vios Works

计划入组 250 人 · 首次发布于 2017 年 4 月 25 日

Heart Arteries and Sickle Cell Disease / Coeur Artères DREpanocytose

计划入组 4,500 人 · 首次发布于 2017 年 4 月 14 日

Pilot Randomized Clinical Study of the Iliac Arteries and Common Femoral Artery With Stenting and the Iliac Arteries With Stenting and Plasty of the Common Femoral Artery

计划入组 60 人 · 首次发布于 2017 年 10 月 20 日

ET1402L1-ARTEMIS T cells

ET190L1 ARTEMIS T Cells

Coronary artery disease gene therapy (BioCardia)

ARTHESYS

France

Artery Therapeutics, Inc.

United States

Anteris Technologies Ltd

Australia

Tempus AI Receives FDA 510(k) Clearance for Enhanced Cardiac Imaging Platform with T1 and T2 Mapping Capabilities

Tempus Partners with Median Technologies to Integrate FDA-Cleared AI Lung Cancer Screening Tool

AI-Enabled Imaging Modalities Market to Surge from $3.62 Billion to $15.16 Billion by 2035, Driven by Deep Learning and Hospital Demand